PolyPeptide Group AG (PPGN) Q4 2023 Earnings Report

4 Followers

CH:PPGN Q4 2023 EPS Results

Actual EPS-CHF0.50

Consensus EPS―

Beat/Miss―

One Year Ago EPS-CHF0.07

Actual RevenueCHF180.60M

Expected RevenueCHF150.32M

Beat/MissBeat by +CHF30.29M

YoY Revenue Growth+25.30%

QuarterQ4 2023

Date03/12/2024

TimeBefore Open

Conference CallTuesday, March 12, 2024

CH:PPGN Upcoming Earnings

PolyPeptide Group AG's next earnings date is estimated for March 9, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 09, 2027	2026 (Q4)	0.47 / -	0.152	―
Aug 13, 2026	2026 (Q2)	0.07 / 0.26	-0.746	134.38% (+1.00)
Mar 12, 2026	2025 (Q4)	0.27 / 0.15	-0.234	164.96% (+0.39)
Aug 12, 2025	2025 (Q2)	-0.53 / -0.75	-0.326	-128.57% (-0.42)
Mar 11, 2025	2024 (Q4)	0.06 / -0.23	-0.499	53.11% (+0.27)
Aug 13, 2024	2024 (Q2)	-0.66 / -0.33	-0.97	66.35% (+0.64)
Mar 12, 2024	2023 (Q4)	- / -0.50	-0.074	-574.32% (-0.42)
Aug 15, 2023	2023 (Q2)	- / -0.97	0.299	-423.99% (-1.27)
Mar 14, 2023	2022 (Q4)	- / -0.07	0.73	-110.14% (-0.80)
Aug 19, 2022	2022 (Q2)	0.29 / 0.32	0.816	-60.66% (-0.49)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed